Gary Goldberg Planning Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$1.02M Buy
48,044
+3,778
+9% +$84.4K 0.43% 46
2014
Q3
$1.05M Sell
44,266
-1,058
-2% -$24.3K 0.44% 51
2014
Q2
$1.05M Buy
45,324
+11,324
+33% +$250K 0.46% 48
2014
Q1
$776K Buy
34,000
+11,930
+54% +$254K 0.38% 51
2013
Q4
$408K Buy
22,070
+4,850
+28% +$84.5K 0.24% 63
2013
Q3
$291K Buy
17,220
+9,850
+134% +$166K 0.18% 76
2013
Q2
$114K Buy
+7,370
New +$123K 0.07% 107

Other funds holding NVO

Gary Goldberg Planning Services's NVO Position: Q4 2014 in Review

Gary Goldberg Planning Services increased its Novo Nordisk (NVO) stake by 8.5% in Q4 2014, buying an estimated $84.4K and bringing the position to 48,044 shares worth $1.02M. The position accounts for 0.43% of the portfolio, ranked #46.

Gary Goldberg Planning Services first reported a position in NVO in Q2 2013 and has held it in 7 quarters since. The position peaked at $1.05M in Q3 2014. 500 funds tracked by Wall St. Rank hold NVO as of Q4 2014.

  • Gary Goldberg Planning Services held 48,044 shares of Novo Nordisk worth $1.02M as of Q4 2014.
  • Gary Goldberg Planning Services bought 3,778 Novo Nordisk shares in Q4 2014, an estimated $84.4K.
  • Novo Nordisk made up 0.43% of Gary Goldberg Planning Services's portfolio in Q4 2014, its #46 holding.
  • Gary Goldberg Planning Services first reported a position in Novo Nordisk in Q2 2013 and has held it in 7 quarters since.
  • Gary Goldberg Planning Services's Novo Nordisk position peaked at $1.05M in Q3 2014.
  • 500 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2014.

Based on Gary Goldberg Planning Services's 13F filing for Q4 2014, filed 9 Feb 2015.